Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT01780116 | Effectiveness of Adherence Therapy for Schizophrenia | PHASE1 | COMPLETED | 134 | — | — | May 1, 2013 | Feb 1, 2016 | Feb 19, 2016 | 2 | Hong Kong |
rate and length of psychiatric hospital readmission immediately, 6 months and 12 months after the completion of the intervention undertaken
| Arm | Type | Description |
|---|---|---|
| Medicaiton adherence therapy | EXPERIMENTAL | Adherence therapy, consisting of six, 2-hour sessions over 3 months, in three phases: 1. Engaging patients: assessing needs and concerns in medication adherence; 2. Reviewing strengths and barriers and developing coping strategies; and 3. Rationalizing beliefs and concerns and preventing relapse. |
| Routine community care | NO_INTERVENTION | Routine Community psychiatric nursing services provided by the Community Psychiatric Nurses in the practice field |
| Name | Type | Description |
|---|---|---|
| Adherence therapy | BEHAVIORAL | Systematic and highly structured medication adherence program using the motivational interviewing (MI) technique that focuses on six principles: expressing empathy, developing discrepancy between client's beliefs and evidence, supporting self-efficacy, avoiding argumentation, and rolling with resistance to behavioral change. MI is often able (with in-depth behavioral analysis) to focus on particular consequences of problem behavior, such as medication non-adherence, that have an obvious impact on patients. |
Inclusion Criteria of the patients include those who: * are Hong Kong Chinese residents; * have a primary diagnosis of schizophrenia or its subtypes such as schizophreniform and schizoaffective disorders not more than 3 years; * have been prescribed oral antipsychotics for at least 1 month; * are a...